| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±5.6% | -2.6% | over-priced |
| 04/30/2026 | ±3.9% | -5.2% | under-priced |
| 02/17/2026 | ±5.5% | -0.1% | over-priced |
| 10/30/2025 | ±3.5% | -3.1% | over-priced |
| 07/31/2025 | ±3.9% | +0.8% | over-priced |
| 05/01/2025 | ±2.7% | -6.4% | under-priced |
| 02/20/2025 | ±3.9% | -0.3% | over-priced |
| 11/05/2024 | ±4.0% | +5.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $-0.04 | $3.9B | $-4M |
| Q1 FY2026 | $-0.43 | $3.3B | $-47M |
| Q4 FY2025 | — | $3.4B | $31M |
| Q3 FY2025 | $1.10 | $3.9B | $122M |
BLDR (BLDR) reports in 2 days, with the next report estimated for 10/29/2026. Across the last 8 reports, options priced an average ±4.1% earnings move while the stock actually moved 2.9% on average — the market has been roughly fair on BLDR's earnings risk. Fundamentals into the print: EPS down 102.4% year-over-year, revenue down 8.8%. QuantLogix's live 5-factor engine currently reads BLDR as a underweight at 41/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →